The same study reported that miR-155 levels are inversely associated with proatherogenic metabolic risk factors (age, hypertension, total cholesterol, and HDL-C, LDL-C, and CRP levels) and the severity of atherosclerotic lesions [35]. This evidence concerns the gene CRP and hypertensive disorder.